Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […]
Philadelphia Trust Co. decreased its holdings in Liquidia Co. (NASDAQ:LQDA – Free Report) by 20.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,000 shares of the company’s stock after selling 2,500 shares during the quarter. Philadelphia Trust Co.’s holdings in Liquidia were worth […]
Philadelphia Trust Co. lessened its stake in shares of Liquidia Co. (NASDAQ:LQDA – Free Report) by 20.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,000 shares of the company’s stock after selling 2,500 shares during the quarter. Philadelphia Trust Co.’s holdings in Liquidia […]
Meridian Wealth Management LLC raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,498 shares of the company’s stock after purchasing an additional 1,275 shares during […]
HC Wainwright reissued their buy rating on shares of Liquidia (NASDAQ:LQDA – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $32.00 price target on the stock. Separately, Needham & Company LLC reiterated a buy rating and set a $28.00 price target on shares of Liquidia in a report […]